From Market Need to Market-Ready

Top: Rabi Musah,  associate professor of Chemistry
Bottom: Doug Conklin, associate professor of Biology and Biomedical Science

Two UAlbany researchers are turning their inventions into market-ready technologies, thanks in part to investments from the Technology Accelerator Fund (TAF).

Funded by the State University of New York (SUNY) and the Research Foundation, TAF bridges funding gaps for SUNY researchers. The program invests in faculty who demon-strate the commercial potential of their idea or innovation. The goal is to increase attractiveness to potential investors.

Associate Professor of Biology and Biomedical Science Doug Conklin and Associate Professor of Chemistry Rabi Musah both recently received TAF funding. Dr. Conklin was awarded for identifying Bruton’s Tyrosine Kinase as a potential novel drug target for breast cancer treatment, while Dr. Musah was recognized for developing a gel electrophoresis dye sensor and controller, which helps with the process of analyzing biomolecular materials such as proteins and nucleic acids.

Since launching in 2011, TAF has invested over $1.5 million to successfully advance the commercial readiness of a number of SUNY-developed innovations. The program has also secured an additional $3.5 million from external partners, including federal agencies, industry licensees and angel investors.